08-31-2023
DKK/share | |
Price | 1,274.00 |
Dividend | 14.14 |
Earnings | 26.21 |
Cash-flow | 36.19 |
Book value | 38.37 |
Equity | 35.37 |
Novo-Nordisk B is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Novo-Nordisk B is a company from Denmark, and his stocks are publicly traded.
Novo-Nordisk B stock dividend
Novo-Nordisk B paid a total dividend of 24,194 million DKK last year, for a market value of 2,179,814 millions (Market Cap 1,992,285 millions). Novo-Nordisk B dividend per share is 14.14 DKK, and his stock market price 1,274.00 DKK.
According to the chart below, where dividend yield is displayed, Novo-Nordisk B has a dividend yield of 1.11%, lower than the amount offered by both the market average and companies from Denmark. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...
In addition, you should compare Novo-Nordisk B stocks dividend with other Pharmaceuticals and Biotechnology companies or other of the highest Denmark dividend stocks list.
Novo-Nordisk B Dividend Payout
About the ability of Novo-Nordisk B to maintain his current dividend of DKK 14.14 per share, an amount that accounts for 1.11%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Novo-Nordisk B payout on ernings is currently 53.95%, which is higher than the market average, and companies of Health Care industry, which are 39.34% and 23.54% respectively. Both figures show that Novo-Nordisk B can have problems to keep with his present dividend yield.
The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Novo-Nordisk B is DKK 36.19 per share, which is higher than the dividend per share paid by the company of DKK 14.14, so the company generates enough cash to maintain his dividend in the future.
The following figure shows payout ratios over earnings and cashflow of Novo-Nordisk B, compared againt world market average, Denmark companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.
Novo-Nordisk B Dividend History
Below you will find a table with the historical evolution of Novo-Nordisk B's dividend stock, both in percentage and in DKK, its Payout on Earnings and the number of shares (in case there is an split, number shares altered the dividend per share).
Year | Yield | DKK | Paypout | Shares* |
Present | 1.11% | 14.14 | 53.95% | 1,711 |
2022 | 1.19% | 11.16 | 49.73% | 1,709 |
2021 | 1.27% | 9.33 | 47.72% | 1,735 |
2020 | 2.02% | 8.62 | 47.89% | 1,765 |
2019 | 2.11% | 8.16 | 47.28% | 1,807 |
2018 | 2.64% | 7.86 | 48.55% | 1,857 |
2017 | 2.27% | 7.59 | 48.78% | 1,922 |
2016 | 3.95% | 9.40 | 66.76% | 2,006 |
2015 | 1.29% | 5.02 | 46.83% | 2,006 |
*In millions
Then you can see the evolution of Novo-Nordisk B dividend stock, and compare it with the average of Denmark stocks and that of the Pharmaceuticals and Biotechnology stocks.
Novo-Nordisk B Stock performance
Finally, last moth Novo-Nordisk B showed a return of 16.60% compared to a worldwide -2.49% average, and a -2.07% of Health Care firms. Over the last year, the company obtained a 60.80% versus a worldwide performance of a 8.71%. More detailed information can be seen in the following graph for Denmark and Pharmaceuticals and Biotechnology firms.